Phenocopy or variant: A longitudinal study of very slowly progressive frontotemporal dementia

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Brodtmann, Amy ^a,b   Cowie, Tiffany ^c   McLean, Catriona ^b   Darby, David ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHARGED MULTIVESICULAR BODY PROTEIN 2B; FLUORODEOXYGLUCOSE F 18; FLUOXETINE; GENOMIC DNA; GRANULIN; MEMBRANE PROTEIN; SERTRALINE; TAU PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN SPONGIOSIS; CASE REPORT; CELL INCLUSION; CELL LOSS; COGNITIVE DEFECT; DISEASE COURSE; FAMILY HISTORY; FRONTAL CORTEX; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; LONGITUDINAL STUDY; LOW DRUG DOSE; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; MOOD DISORDER; NERVE CELL; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 84875968950     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-008077     Document Type: Article

References (16)

1. Garcin B, Lillo P, Hornberger M, et al. Determinants of survival in behavioral variant frontotemporal dementia. Neurology 2009;73:1656-61.
2. Coon EA, Sorenson EJ, Whitwell JL, et al. Predicting survival in frontotemporal dementia with motor neuron disease. Neurology 2011;76:1886-93.
3. Hodges JR, Davies R, Xuereb J, et al. Survival in frontotemporal dementia. Neurology 2003;61:349-54. (Pubitemid 36975964)
4. Seelaar H, Rohrer JD, Pijnenburg YA, et al. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 2011;82:476-86.
5. Davies RR, Kipps CM, Mitchell J, et al. Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch Neurol 2006;63:1627-31. (Pubitemid 44748807)
6. Hornberger M, Shelley KP, Kipps CM, et al. Can progressive and non-progressive behavioral variant frontotemporal dementia be distinguished at presentation? J Neurol Neurosurg Psychiatry 2009;80:5913.
7. Kipps CM, Hodges JR, Hornberger M. Nonprogressive behavioural frontotemporal dementia: recent developments and clinical implications of the 'bvFTD phenocopy syndrome'. Curr Opin Neurol 2010;23:628-32.
8. Klein C, Bonifati V. Dissecting the complexity of frontotemporal dementia: genotypes, phenotypes, and phenocopies. Neurology 2007;69:129-30. (Pubitemid 47051715)
9. Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 2010;119:14.
10. Kaivorinne AL, Kruger K, Udd B, et al. Mutations in CHMP2B are not a cause of frontotemporal lobar degeneration in Finnish patients. Eur J Neurol 2010;17:13935.
11. Cannon A, Baker M, Boeve B, et al. CHMP2B mutations are not a common cause of frontotemporal lobar degeneration. Neurosci Lett 2006;398:834.
12. Kipps CM, Nestor PJ, Fryer TD, et al. Behavioural variant frontotemporal dementia: not all it seems? Neurocase 2007;13:237-47. (Pubitemid 350153953)
13. Mioshi E,, Hodges Jr.. Rate of change of functional abilities in frontotemporal dementia. Dement Geriatr Cogn Disord 2009;28:419-26.
14. Khan BK, Yokoyama JS, Takada LT, et al. Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J Neurol Neurosurg Psychiatry 2012;83:358-64.
15. Rohrer JD, Warren JD, Omar R, et al. Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Arch Neurol 2008;65:506-13. (Pubitemid 351549960)
16. Parkinson N, Ince PG, Smith MO, et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 2006;67:1074-7.